Minimal hepatic encephalopathy - from cirrhosis to neurological disorders
DOI:
https://doi.org/10.12775/JEHS.2024.76.56382Keywords
minimal hepatic encephalopathy, hepatic encephalopathy, cirrhosis, sibo, hyperamonemiaAbstract
Introduction and aim
Minimal hepatic encephalopathy (MHE) is a subtle but significant brain dysfunction resulting from chronic liver damage, with symptoms that can be difficult to detect. It affects patients' quality of life by causing problems with concentration, memory, and motor coordination. Untreated MHE may progress to more severe neurological disorders, such as overt hepatic encephalopathy. The importance of this condition lies in its impact on patients' daily functioning and the increased risk of accidents, particularly in situations requiring quick responses, such as driving.Neurological symptoms caused by the disease are potentially reversible with treatment.
Materials and Methods
Available literature from the PubMed and Google Scholar databases was reviewed using the following keywords: "minimal hepatic encephalopathy," "hepatic encephalopathy," "cirrhosis," and "SIBO."
Conclusion
The significance of Minimal Hepatic Encephalopathy is crucial from the perspective of preventing further progression and the onset of overt hepatic encephalopathy, as well as improving the quality of life for our patients. Patients and their families are often unaware of the condition, and the cognitive impairments are frequently underestimated. Enhancing diagnostic methods would enable physicians to identify these patients more promptly.
References
Ortiz, María, Carlos Jacas, and Juan Córdoba. "Minimal hepatic encephalopathy: diagnosis, clinical significance and recommendations." Journal of hepatology 42.1 (2005): S45-S53.
Stinton, Laura M., and Saumya Jayakumar. "Minimal hepatic encephalopathy." Canadian Journal of Gastroenterology and Hepatology 27.10 (2013): 572-574.
Pisarek, Wojciech. "Minimal hepatic encephalopathy – diagnosis and treatment." Gastroenterology Review/Przegląd Gastroenterologiczny, vol. 16, no. 4, 2021, pp. 311-317. doi:10.5114/pg.2021.111389.
Dhiman RK, Saraswat VA, Sharma BK, Sarin SK, Chawla YK, Butterworth R i in. Minimalna encefalopatia wątrobowa: oświadczenie konsensusu grupy roboczej Indyjskiego Krajowego Stowarzyszenia Badań nad Wątrobą. J Gastroenterol Hepatol. 2010;25:1029–1041. doi: 10.1111/j.1440-1746.2010.06318.x.
Schomerus, H., & Hamster, W. (2001). Quality of life in cirrhotics with minimal hepatic encephalopathy. Metabolic brain disease, 16, 37-41.
Ridola, L., Nardelli, S., Gioia, S., & Riggio, O. (2018). Quality of life in patients with minimal hepatic encephalopathy. World journal of gastroenterology, 24(48), 5446.
Gairing, Simon Johannes, et al. "Minimal hepatic encephalopathy is associated with a higher risk of overt hepatic encephalopathy and poorer survival." Journal of internal medicine 295.3 (2024): 331-345.
European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu. and European Association for the Study of the Liver. “EASL Clinical Practice Guidelines on the management of hepatic encephalopathy.” Journal of hepatology vol. 77,3 (2022): 807-824. doi:10.1016/j.jhep.2022.06.001
Labenz C , Baron JS , Toenges G , Schattenberg JM , Nagel M , Sprinzl MF , i in. Prospektywna ocena wpływu ukrytej encefalopatii wątrobowej na jakość życia i sen u pacjentów z marskością wątroby . Aliment Pharmacol Ther. 2018 ; 48 : 313 – 321 .
Kazimierska, Iwona. "Zaburzenia psychiczne i neurologiczne u pacjentów z marskością wątroby." Kurier Medyczny 2021.5: 24-25.
Vilstrup, Hendrik, et al. "Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver." Hepatology 60.2 (2014): 715-735.
Ridola, L., Faccioli, J., Nardelli, S., Gioia, S., & Riggio, O. (2020). Hepatic encephalopathy: diagnosis and management. Journal of Translational Internal Medicine, 8(4), 210-219.
Häussinger, D., Dhiman, R. K., Felipo, V., Görg, B., Jalan, R., Kircheis, G., ... & Vilstrup, H. (2022). Hepatic encephalopathy. Nature Reviews Disease Primers, 8(1), 43.
Grata-Borkowska, U., Susło, R., Hańczyc, P., Michalska, M., Lewera, D., & Drobnik, J. (2016). Zaburzenia psychiczne i neurologiczne u pacjentów z encefalopatią wątrobową. Psychiatria, 13(4), 203-209.
Bogdanowska-Charkiewicz, Dagmara, et al. "Minimal hepatic encephalopathy–underestimated complication of chronic liver disease." Neuropsychiatria i Neuropsychologia/Neuropsychiatry and Neuropsychology 16.1 (2021): 32-40.
Rose, Christopher F., et al. "Hepatic encephalopathy: Novel insights into classification, pathophysiology and therapy." Journal of hepatology 73.6 (2020): 1526-1547.
Zhan T, Stremmel W. The diagnosis and treatment of minimal hepatic encephalopathy. Dtsch Arztebl Int. 2012 Mar;109(10):180-7. doi: 10.3238/arztebl.2012.0180. Epub 2012 Mar 9. PMID: 22470407; PMCID: PMC3317375.
Perspective from Magnetic Resonance Imaging." Journal of Magnetic Resonance Imaging (2023).
Hansen, Mads Kingo Guldberg, et al. "Psychometric methods for diagnosing and monitoring minimal hepatic encephalopathy—current validation level and practical use." Metabolic Brain Disease 37.3 (2022): 589-605.
Wunsch, Ewa et al. “Normalization of the psychometric hepatic encephalopathy score in Polish population. A prospective, quantified electroencephalography study.” Liver international : official journal of the International Association for the Study of the Liver vol. 33,9 (2013): 1332-40. doi:10.1111/liv.12194
Singh, Parul, and Syed Azmal Ali. "Multifunctional role of S100 protein family in the immune system: an update." Cells 11.15 (2022): 2274.
Michetti, Fabrizio, et al. "The S100B protein: A multifaceted pathogenic factor more than a biomarker." International Journal of Molecular Sciences 24.11 (2023): 9605.
Nelson, Heather A., et al. "Mitigation of biotin interference in manual and automated immunoassays by preconjugating biotinylated antibodies to the streptavidin surface as an alternative to biotin depletion." The Journal of Applied Laboratory Medicine 7.3 (2022): 762-775.
Pisarek, Wojciech. "S100 Beta Protein as a Marker of Hepatic Encephalopathy: A Breakthrough in Diagnostics or a False Trail? Review of the Literature." Postępy Higieny i Medycyny Doświadczalnej 76.1 (2022): 128-131.
Strebel H, Haller B, Sohn M, Schepp W, Gundling F. Role of brain biomarkers S-100-beta and neuron-specific enolase for detection and follow-up of hepatic encephalopathy in cirrhosis before, during and after treatment with L-ornithine-L-aspartate. GE - Port J Gastroenterol. 2020; 27: 391-403.
Abid, Shahab, et al. "Minimal Hepatic Encephalopathy: Effect of H. pylori infection and small intestinal bacterial overgrowth treatment on clinical outcomes." Scientific reports 10.1 (2020): 10079.
Sroka, Natalia, et al. "Show Me What You Have Inside—The Complex Interplay between SIBO and Multiple Medical Conditions—A Systematic Review." Nutrients 15.1 (2022): 90.
Donaldson GP, Ladinsky MS, Yu KB, Sanders JG, Yoo BB, Chou WC, Conner ME, Earl AM, Knight R, Bjorkman PJ, Mazmanian SK. Mikrobiota jelitowa wykorzystuje immunoglobulinę A do kolonizacji błony śluzowej. Science. 2018;360:795–800. doi: 10.1126/science.aaq0926.
Qin N, Yang F, Li A, Prifti E, Chen Y, Shao L, Guo J, Le Chatelier E, Yao J, Wu L, Zhou J, Ni S, Liu L, Pons N, Batto JM, Kennedy SP, Leonard P, Yuan C, Ding W, Hu X, Zheng B, Qian G, Xu W, Ehrlich SD, Zheng S, Li L. Zmiany mikrobiomu jelit ludzkich w marskości wątroby. Nature. 2014;513:59–64. doi: 10.1038/nature13568.
Dhiman, Radha K., et al. "Comparative efficacy of treatment options for minimal hepatic encephalopathy: a systematic review and network meta-analysis." Clinical gastroenterology and hepatology 18.4 (2020): 800-812.
Adamczyk, M. D. (2018). Specyfika procesów starzenia się społeczeństwa polskiego w kontekście wskaźników zrównoważonego rozwoju. Wybrane problemy społeczne. Teraźniejszość–Przyszłość, 112-122.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Jakub Jarmołowicz, Agata Boczar, Patryk Dryja, Sven Solisch, Izabela Stawicka, Izabela Orzołek
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 41
Number of citations: 0